Literature DB >> 149174

Effects of costimulator on immune responses in vitro.

J Shaw, V Monticone, G Mills, V Paetkau.   

Abstract

We recently described a factor, costimulator, that is required for the concanavalin A-induced proliferation of CBA mouse thymocytes in vitro (see Reference 1). Using the costimulator dependence of mouse thymocytes as an assay, we have now determined that spleen cells from congenitally athymic (nude) BALB/c mice do not produce costimulator in response to Con A, and spleen cells depleted of Thy 1-positive cells do not respond to it in the presence of Con A. Thus, costimulator both requires thymus-derived (Thy 1+ lymphocytes for its production and has an effect on this type of cell. (However, the costimulator-producing and responsive cells may be different.) Purified costimulator preparations are a source of the required second component for the stimulation of adult, CBA/J thymic lymphocytes by PHA, normally a poor mitogen for these cells. They also enhance the level of DNA synthesis in a mixed leukocyte reaction, and the specific generation of cytotoxic lymphocytes to allogeneic tumor cells in vitro. Costimulator is not H-2 restricted in its effects, and it is produced in mixed leukocyte reactions. Finally, it has been possible to grow normal, primary thymic lymphocytes in culture for about 20 days by adding partially purified costimulator to the cultures.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 149174

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Cloning of two genes that are specifically expressed in activated cytotoxic T lymphocytes.

Authors:  C G Lobe; C Havele; R C Bleackley
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 2.  T cell clones: their use for the study of specificity, induction, and effector-function of T cells.

Authors:  H von Boehmer; W Haas; H Pohlit; H Hengartner; M Nabholz
Journal:  Springer Semin Immunopathol       Date:  1980-05

Review 3.  [The role of interleukin-2 during the activation of cytotoxic T-lymphocytes].

Authors:  W Solbach; M Röllinghoff; H Wagner
Journal:  Klin Wochenschr       Date:  1983-01-17

4.  Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

Authors:  M Howard; J Farrar; M Hilfiker; B Johnson; K Takatsu; T Hamaoka; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

5.  Delayed-type hypersensitivity and allograft rejection in the mouse: correlation of effector cell phenotype.

Authors:  B E Loveland; I F McKenzie
Journal:  Immunology       Date:  1982-06       Impact factor: 7.397

6.  Phylogeny of interleukins: growth factors produced by leucocytes of the cyprinid fish, Cyprinus carpio L.

Authors:  J L Grondel; E G Harmsen
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

7.  Effect of recombinant human interleukin-2 on the course of experimental chronic respiratory tract infection caused by Klebsiella pneumoniae in mice.

Authors:  Y Iizawa; T Nishi; M Kondo; K Tsuchiya; A Imada
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

8.  Purification and properties of a factor from leukaemic T cells which non-specifically enhances the antibody response.

Authors:  H L Mulcahy; A S Rubin; A B MacDonald
Journal:  Immunology       Date:  1981-01       Impact factor: 7.397

9.  Deficit of interleukin 2 production associated with impaired T-cell proliferative responses in Mycobacterium lepraemurium infection.

Authors:  A Hoffenbach; P H Lagrange; M A Bach
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Toward a molecular understanding of adaptive immunity: a chronology - part II.

Authors:  Kendall A Smith
Journal:  Front Immunol       Date:  2012-11-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.